Amphastar Pharmaceuticals Inc (AMPH) – Company Profile and SWOT Analysis

Amphastar Pharmaceuticals Inc (AMPH) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Amphastar Pharmaceuticals Inc (Amphastar) is a biopharmaceutical company. The company focuses on developing, manufacturing, and marketing generic and proprietary injectable, intranasal and inhalation products. It also sells insulin-active pharmaceutical ingredient products. The company’s product portfolio includes glucagon nasal powder, enoxaparin sodium injection, cosyntropin injection, naloxone hydrochloride injection, phytonadione injection, lidocaine jelly, amphadase hyaluronidase injection and primatene mist among others. Amphastar offers its products to hospitals, long-term care facilities, alternate care sites, clinics, and doctors’ offices, and retail pharmacies. The company distributes its products through specialty distributors, wholesalers and retailers in the US, France and China. Amphastar is headquartered in Rancho Cucamonga, California, the US.

Scope

• Detailed information on Amphastar Pharmaceuticals Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Amphastar Pharmaceuticals Inc in the form of a SWOT analysis

• An in-depth view of the business model of Amphastar Pharmaceuticals Inc including a breakdown and examination of key business segments

• News about Amphastar Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Amphastar Pharmaceuticals Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Amphastar Pharmaceuticals Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Amphastar Pharmaceuticals Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Mylan Inc

Eli Lilly and Co

American Regent Inc

Pfizer Inc

Sandoz Inc

Cipla USA Inc

Amneal Biosciences LLC

Nexus Pharmaceuticals Inc

Apotex Corp

Teva Pharmaceutical Industries Ltd

Hikma Pharmaceuticals USA Inc

Sanofi

OptiNose Inc

Meitheal Pharmaceuticals Inc

Sagent Pharmaceuticals Inc

Fresenius Kabi USA LLC

Dr. Reddy's Laboratories Ltd

Akorn Operating Company LLC

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Amphastar Pharmaceuticals Inc - Key Facts

Amphastar Pharmaceuticals Inc - Key Employees

Amphastar Pharmaceuticals Inc - Key Employee Biographies

Amphastar Pharmaceuticals Inc - Major Products and Services

Amphastar Pharmaceuticals Inc - History

Amphastar Pharmaceuticals Inc - Company Statement

Amphastar Pharmaceuticals Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Amphastar Pharmaceuticals Inc - Business Description

Business Segment: Active Pharmaceutical Ingredients (API)

Overview

Performance

Business Segment: Finished Pharmaceutical Products

Overview

Performance

Geographical Segment: China

Performance

Geographical Segment: France

Performance

Geographical Segment: United States

Performance

R&D Overview

Amphastar Pharmaceuticals Inc - Corporate Strategy

Amphastar Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

Amphastar Pharmaceuticals Inc - Strengths

Amphastar Pharmaceuticals Inc - Weaknesses

Amphastar Pharmaceuticals Inc - Opportunities

Amphastar Pharmaceuticals Inc - Threats

Amphastar Pharmaceuticals Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024

Amphastar Pharmaceuticals Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 08, 2024: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024

Apr 30, 2024: FTC Expands Patent Listing Challenges, Targeting More Than 300 Junk Listings for Diabetes, Weight Loss, Asthma and COPD Drugs

Feb 28, 2024: Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023

Aug 02, 2023: Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023

May 10, 2023: Amphastar Pharmaceuticals reports financial results for the three months ended March 31, 2023

Feb 28, 2023: Amphastar Pharmaceuticals reports financial results for the three months and full-Year ended December 31, 2022

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Amphastar Pharmaceuticals Inc, Key Facts

Amphastar Pharmaceuticals Inc, Key Employees

Amphastar Pharmaceuticals Inc, Key Employee Biographies

Amphastar Pharmaceuticals Inc, Major Products and Services

Amphastar Pharmaceuticals Inc, History

Amphastar Pharmaceuticals Inc, Other Locations

Amphastar Pharmaceuticals Inc, Subsidiaries

Amphastar Pharmaceuticals Inc, Key Competitors

Amphastar Pharmaceuticals Inc, Ratios based on current share price

Amphastar Pharmaceuticals Inc, Annual Ratios

Amphastar Pharmaceuticals Inc, Annual Ratios (Cont…1)

Amphastar Pharmaceuticals Inc, Annual Ratios (Cont…2)

Amphastar Pharmaceuticals Inc, Interim Ratios

Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024

Amphastar Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Amphastar Pharmaceuticals Inc, Performance Chart (2019 – 2023)

Amphastar Pharmaceuticals Inc, Ratio Charts

Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports